FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1489726069> ?p ?o ?g. }

• W1489726069 endingPage "1037" @default.
• W1489726069 startingPage "1030" @default.
• W1489726069 abstract "To cite this article: Schaub A, von Gunten S, Vogel M, Wymann S, Rüegsegger M, Stadler BM, Spycher M, Simon H-U, Miescher S. Dimeric IVIG contains natural anti-Siglec-9 autoantibodies and their anti-idiotypes. Allergy 2011; 66: 1030–1037. Background: Intravenous immunoglobulin (IVIG) preparations are increasingly used for the treatment of autoimmune and chronic inflammatory diseases. Naturally occurring autoantibodies against Siglec-9 and Fas are thought to contribute to the anti-inflammatory effects of IVIG via cell death regulation of leukocytes and tissue cells. Dimeric IVIG fractions are suspected to contain idiotypic (Id)-anti-idiotypic complexes of antibodies, which might also include anti-Siglec-9 and anti-Fas autoantibodies. Methods: Dimeric IVIG fractions were separated from monomeric IVIG by size-exclusion chromatography and remonomerized by low pH treatment. Binding studies of total, monomeric, and dimeric IVIG were performed using surface plasmon resonance and flow cytometry on primary human neutrophils. Results: Anti-Siglec-9 and anti-Fas autoantibodies were contained in both monomeric and dimeric IVIG fractions, but anti-Siglec-9 antibodies were highly enriched in dimeric IVIG. The propensity to engage in dimer formation was paratope dependent. IVIG binding to Siglec-9 was specific and sialylation independent. Interestingly, we detected anti-idiotypic antibodies (anti-Ids) against anti-Siglec-9 autoantibodies in dimeric, but not in monomeric fractions of IVIG. Conclusions: Our study supports the concept that idiotype–anti-idiotype (Id–anti-Id) interactions contribute to the dimer formation in IVIG preparations. To our knowledge, this is the first description of Id–anti-Id dimers of death receptor-specific antibodies in IVIG. Such Id–anti-Id interactions might determine the activity of immunomodulatory antibodies present both in IVIG and the patient." @default.
• W1489726069 created "2016-06-24" @default.
• W1489726069 creator A5012299806 @default.
• W1489726069 creator A5018979672 @default.
• W1489726069 creator A5049116947 @default.
• W1489726069 creator A5052140879 @default.
• W1489726069 creator A5060623336 @default.
• W1489726069 creator A5062676514 @default.
• W1489726069 creator A5069802631 @default.
• W1489726069 creator A5071716066 @default.
• W1489726069 creator A5075179391 @default.
• W1489726069 date "2011-03-09" @default.
• W1489726069 modified "2023-10-18" @default.
• W1489726069 title "Dimeric IVIG contains natural anti-Siglec-9 autoantibodies and their anti-idiotypes" @default.
• W1489726069 cites W1487397714 @default.
• W1489726069 cites W1495224833 @default.
• W1489726069 cites W1497904783 @default.
• W1489726069 cites W1563183497 @default.
• W1489726069 cites W1957823630 @default.
• W1489726069 cites W1966455480 @default.
• W1489726069 cites W1971907885 @default.
• W1489726069 cites W1975336660 @default.
• W1489726069 cites W1989175504 @default.
• W1489726069 cites W1996177911 @default.
• W1489726069 cites W2002401872 @default.
• W1489726069 cites W2010167908 @default.
• W1489726069 cites W2011670785 @default.
• W1489726069 cites W2015423349 @default.
• W1489726069 cites W2023539775 @default.
• W1489726069 cites W2035433348 @default.
• W1489726069 cites W2041588298 @default.
• W1489726069 cites W2042966355 @default.
• W1489726069 cites W2051666192 @default.
• W1489726069 cites W2059456135 @default.
• W1489726069 cites W2060056853 @default.
• W1489726069 cites W2066248629 @default.
• W1489726069 cites W2070255464 @default.
• W1489726069 cites W2083503004 @default.
• W1489726069 cites W2084516448 @default.
• W1489726069 cites W2095563526 @default.
• W1489726069 cites W2119008187 @default.
• W1489726069 cites W2134530898 @default.
• W1489726069 cites W2137658161 @default.
• W1489726069 cites W2153279287 @default.
• W1489726069 cites W2616639792 @default.
• W1489726069 cites W3116890861 @default.
• W1489726069 doi "https://doi.org/10.1111/j.1398-9995.2011.02579.x" @default.
• W1489726069 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21385183" @default.
• W1489726069 hasPublicationYear "2011" @default.
• W1489726069 type Work @default.
• W1489726069 sameAs 1489726069 @default.
• W1489726069 citedByCount "38" @default.
• W1489726069 countsByYear W14897260692012 @default.
• W1489726069 countsByYear W14897260692013 @default.
• W1489726069 countsByYear W14897260692014 @default.
• W1489726069 countsByYear W14897260692015 @default.
• W1489726069 countsByYear W14897260692016 @default.
• W1489726069 countsByYear W14897260692017 @default.
• W1489726069 countsByYear W14897260692018 @default.
• W1489726069 countsByYear W14897260692020 @default.
• W1489726069 countsByYear W14897260692021 @default.
• W1489726069 countsByYear W14897260692022 @default.
• W1489726069 countsByYear W14897260692023 @default.
• W1489726069 crossrefType "journal-article" @default.
• W1489726069 hasAuthorship W1489726069A5012299806 @default.
• W1489726069 hasAuthorship W1489726069A5018979672 @default.
• W1489726069 hasAuthorship W1489726069A5049116947 @default.
• W1489726069 hasAuthorship W1489726069A5052140879 @default.
• W1489726069 hasAuthorship W1489726069A5060623336 @default.
• W1489726069 hasAuthorship W1489726069A5062676514 @default.
• W1489726069 hasAuthorship W1489726069A5069802631 @default.
• W1489726069 hasAuthorship W1489726069A5071716066 @default.
• W1489726069 hasAuthorship W1489726069A5075179391 @default.
• W1489726069 hasConcept C141105273 @default.
• W1489726069 hasConcept C159654299 @default.
• W1489726069 hasConcept C163764329 @default.
• W1489726069 hasConcept C185592680 @default.
• W1489726069 hasConcept C195616568 @default.
• W1489726069 hasConcept C203014093 @default.
• W1489726069 hasConcept C2778017598 @default.
• W1489726069 hasConcept C542903549 @default.
• W1489726069 hasConcept C71924100 @default.
• W1489726069 hasConcept C74505204 @default.
• W1489726069 hasConcept C9086966 @default.
• W1489726069 hasConceptScore W1489726069C141105273 @default.
• W1489726069 hasConceptScore W1489726069C159654299 @default.
• W1489726069 hasConceptScore W1489726069C163764329 @default.
• W1489726069 hasConceptScore W1489726069C185592680 @default.
• W1489726069 hasConceptScore W1489726069C195616568 @default.
• W1489726069 hasConceptScore W1489726069C203014093 @default.
• W1489726069 hasConceptScore W1489726069C2778017598 @default.
• W1489726069 hasConceptScore W1489726069C542903549 @default.
• W1489726069 hasConceptScore W1489726069C71924100 @default.
• W1489726069 hasConceptScore W1489726069C74505204 @default.
• W1489726069 hasConceptScore W1489726069C9086966 @default.
• W1489726069 hasIssue "8" @default.
• W1489726069 hasLocation W14897260691 @default.
• W1489726069 hasLocation W14897260692 @default.

• next